Related Experiment Video
Updated: Feb 27, 2026
05:39
Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
2.2K
Circulating CD89-IgA complex does not predict deterioration of kidney function in Korean patients with IgA
Clinical Chemistry and Laboratory Medicine
|July 5, 2017
Summary
Soluble CD89 (sCD89)-IgA complex does not predict disease progression in IgA nephropathy (IgAN). This study found no association between sCD89-IgA levels and adverse outcomes, limiting its clinical utility for IgAN risk stratification.
Area of Science:
- Nephrology
- Immunology
- Biomarker Discovery
Background:
- Soluble CD89 (sCD89)-IgA complex is implicated in IgA nephropathy (IgAN) pathogenesis.
- Evidence for sCD89-IgA as a biomarker for IgAN progression is limited.
- This study evaluated sCD89-IgA complex for IgAN risk stratification.
Purpose of the Study:
- To assess the utility of sCD89-IgA complex levels in predicting disease progression in IgA nephropathy (IgAN).
- To determine if sCD89-IgA complex can serve as a biomarker for risk stratification in IgAN patients.
Main Methods:
- Included 326 patients with biopsy-proven IgAN.
- Measured sCD89-IgA complex using sandwich-ELISA.
- Assessed 30% decline in estimated glomerular filtration rate (eGFR) as the primary endpoint.
Main Results:
- sCD89-IgA levels showed a weak inverse association with eGFR at biopsy (p=0.03), which lost significance in multivariate analysis (p=0.75).
- No association was found between sCD89-IgA complex levels and the risk of a 30% eGFR decline in Cox models.
- sCD89-IgA complex did not outperform clinical factors in predicting IgAN disease progression.
Conclusions:
- sCD89-IgA complex levels are not associated with disease progression in IgAN.
- Despite sCD89's role in immune complex formation, sCD89-IgA levels lack predictive value for adverse outcomes.
- The clinical utility of sCD89-IgA complex for risk stratification in IgAN is limited.
More Related Videos
14:18Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
Published on: October 13, 2023
1.8K
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
3.6K
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
387
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
387
01:28Chronic Kidney Disease III: Interprofessional Care
529
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
529
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
282
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
282
01:29Acute Kidney Injury III: Clinical Manifestations
1.1K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K
01:24Chronic Kidney Disease II: Clinical Manifestations
795
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
795
01:25Chronic Kidney Disease I: Introduction
863
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
863